Market Research Blog

The biomedical refrigerators and freezers market is projected to record a CAGR of 5.9% during the forecast period, up from US$ 3.2 Bn in 2020 to reach a valuation of US$ 6 Bn by 2031

Biomedical refrigerators and freezers are medical equipment, used for storing various biological samples such as biological reagents, blood, blood derivatives, medicines, vaccines, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and flammable chemicals. Samples with biological origin require precise conditions for effective storage.

In comparison with domestic refrigerators and freezers, biomedical refrigerators and freezers provide optimum conditions for efficient storage of samples with biological origin. Biomedical refrigerators and freezers are widely used in blood banks, hospitals, diagnostic centers, research laboratories, educational institutes, etc.

Based on temperature range, commercially available biomedical refrigerators and freezers offer different applications.

For example, ultra-low temperature freezers with temperature range between -70 to -80 and low are used for prolonged storage of biomedical samples such as DNA and RNA. Plasma freezers offer temperature range between -30°C to -40°C and hence, are preferred for the storage of plasma products, whole blood and vaccines.

Blood bank refrigerators are suited for the storage of whole blood or blood component products. However, the blood bank refrigerators segment contributes the largest market share for the global biomedical refrigerators and freezers market.

The blood bank refrigerators segment is mainly driven by steady rise in the number of blood banks in developing and developed regions and the presence of stringent regulatory requirements. On the other hand, laboratory, medical freezers and pharmacy segments are expected to grow with fastest CAGR during the forecast period.

The global biomedical refrigerator and freezer market is expected to grow at a single digit CAGR during the forecast period (2015-2025).

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1051

Global Biomedical Refrigerators and Freezers Market: Overview

With rapid technological advancement and with augmentation of various technological and infrastructural up gradation of clinics, hospitals and research laboratories, the global biomedical refrigerators and freezers is expected to have a substantial growth in the forecast period (2015-2025).

For more insights into the market, request a sample of this report Global Biomedical Refrigerators and Freezers Market: Key Players

Key players in global biomedical refrigerators and freezers market are, Aegis Scientific, Inc., ARCTIKO A/S, ThermoFisher Scientific, Inc., Binder GmbH, BioMedical Solutions, Inc., Bionics Scientific Technologies (P) Ltd., Coldway, DESMON S.p.A, Eppendorf AG, Froilabo SAS, Panasonic Healthcare Co., Ltd., Philipp Kirsch GmbH, LabRepCo, Inc., Gram Commercial A/S, and Venktron Electronics Co. Ltd.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1051

Global Biomedical Refrigerators and Freezers Market: Drivers and Restraints

Factors driving the global biomedical refrigerators and freezers market, are increasing demand for blood transfusions, custom-made medicines and vaccines, and cellular therapies. In addition, rising research and development activities in the field of medical science are driving the acceptance of biomedical refrigerators and freezers in research and educational institutes.

Also, with increased funding from various sources and R&D activities in the pharmaceutical sector up-surged the use of biomedical refrigerators and freezers.

Factors restraining the global refrigerator and freezers market includes, presence of large number of local players offering cheaper products than branded products, and rising trend of using refurbished equipment worldwide due to its cheaper price.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-1051

Have a Look at More Valuable Insights of Healthcare

Saudi Arabia Pharmaceutical Market Size is estimated to be valued at US$ 5,209.5 Mn by 2016 end and is expected to expand at a CAGR of 9.0% over the forecast period (2016–2026)

Cancer Diagnostics Market Share  is projected to expand steadily at a CAGR 7.1% value, during the forecast period 2022-2032

Continuous Renal Replacement Therapy Market Demand is valued at US$ 1 Billion in 2021. The market is likely to grow at a CAGR of 7.7% through 2027, reaching US$ 1.68 Billion

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

According to a recent study done by FMI, The global micropump market is projected to grow at a CAGR of 19% and will reach US$ 10 Bn by 2032 from US$ 1.6 Bn in 2021.. This study explains how the micropump market is directly proportional to increasing technological advancements and rising demand for micropumps during care testing. The micropumps include micropump gj, micropump ga, etc.

The rising awareness and importance of controlled drug delivery are helping the market rise up. Also, increasing demand for miniatured medical devices is helping the global micropump market grow excessively.

The use of micropumps in nasal and pulmonary routes drug delivery is another driving factor for the global market as awareness also increases around control drug delivery in order to gain a positive impact. Micropumps like waterway micropump, cole parmer micropumps are used to help the accurate drug delivery processes.

The rising application of micropump in infusion therapy, added with its usage in biomedical research, is a significant factor that will help the global market thrive. For instance, a high-pressure micropump is used in biomedical research.

As Covid-19 has impacted the global market, micro-dosing pumps are used in the research and development programs, and its use in therapy is another reason for the increasing growth of the market.

Key Takeaway

• The government research and development programs demand the most from the global micropump market. Huge investments are made in testing new healthcare drugs post covid-19 surge to eliminate the potential threat.
• The drug delivery applications help the market thrive as it requires micropumps in order to complete the processes. The use of micropumps such as vacuum micropumps servoflo micropump is common in drug delivery applications.
• North America region is the biggest market for the global micropump market as it will hold the largest portion of the market in the forecast period. The growth is owed and led by the use of micropumps in medical research.
• The global market is segmented by End-user, Application, and Product Type. These categories are further divided into small segments.

• On the basis of End-user, the performing segment is biotechnology and pharmaceuticals companies. The reason behind this growth is the huge government investments in R&D. Micropumps like piezoelectric micropump, idex micropump, or pump drives like micropump eagle drive are used in the R&D programs.
• On the basis of Application, the biggest segment is the in-vitro diagnostics is the performing segment as the IVF market is blooming sideways.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14339

Competitive Landscape

The global Micropump market is dominated by Sensile Medical, Cole-Parmer India Pvt ltd, IDEX, Dolomite Microfluidics, The Lee Company, Gardner Denver, Takasago Electric Inc, Hama Plc, and Servoflo Corporation. These companies are adopting new digital channels and processes to increase their stronghold in the Micropump market.

•        TTP Ventus has introduced its new product line that is called the LT series. This includes pump products with advanced operational capabilities and ready for use in life sciences, medical, industrial research, and environmental sectors.
• TTP Ventus ltd. also has launched a new range of micropumps named HP series that deliver optimum performance in higher pressures, higher flow rates, and long life for advanced applications.

Key Segments

By Product Type:

• Mechanical Micropump
  • Piezoelectric Micropump
  • Peristaltic Micropump
• Others

By Application:

• Drug Delivery
• In-Vitro Diagnostics
• Medical Devices
• Others

By End User:

• Biotechnology & Pharmaceutical Companies
• Hospitals & Diagnostic Centres
• Academic & Research Institutes

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14339

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Fact.MR Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Micropump Demand

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-14339

Explore wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape:

Knotless Tissue Control Devices Market Forecast is projected to secure a market value worth US$ 672.6 Million by 2032. In 2022, the market is projected at US$ 465.6 Million

Reverse Transcriptase Enzymes Market Size is anticipated to rise to US$ 335.0 Million in 2022. The reverse transcriptase enzymes market is likely to reach US$ 481.8 Million with a CAGR of 3.4% by 2032

Large Volume Wearable Injectors Market Share is anticipated to be valued at US$ 2,800.0 Million in 2022, forecast to grow at a CAGR of 8.9% to be valued at US$ 7,142.3 Million from 2022 to 2032

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

The global needle-free injectors market is likely to accumulate value of US$ 13.78 Billion in 2022, and is expected to reach US$ 13.78 Billion by registering a CAGR of 12% in the forecast period 2022-2032.

Needle-free injection is an innovative drug delivery technology that drives drugs to the skin using force which virtually nullifies the use of hypodermic needle. With growing preference for non-invasive drug delivery system and vaccines, adoption of needle-free injectors is expected to improve over the coming years

Application of needle-free injectors is increasing with rising incidence of diabetes and other chronic diseases across the globe. With increasing number of surgeries, demand for minimally invasive procedures is accelerating the sales of needle-free injectors.

According to Centers for Disease Control and Prevention (CDC), more than 51% of adults in U.S. had at least 1 chronic condition, and 27.2% had multiple chronic conditions in 2018.

Other factors driving the global demand are cost-effectiveness and safety related to needle-free injectors.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13960

Key Takeaways from Needle-free Injectors Market study

• By load type, liquid injections segment will hold around 88.0% of value share globally.
• Based on the technology, spring-loaded jet injector is dominating the market, with over 48.0% of the market share.
• Based on the delivery site, intra dermal injector is expected to hold over 33% of the market share.
• Application of drug delivery will spur the sales of needle-free injectors, with the segment accounting for 65% of the market share.
• Based on the usage, reusable needle free injectors are highly sought-after, contributing over 78% of the market revenue.
• Hospitals are expected to be the primary end-users, holding a market share of 28% during the forecast period.
• By region, North America will dominate the global needle-free injectors market, holding 42% of total market share.
• Europe is expected to be the second-largest market, with Germany spearheading the market growth .
• India will emerge as the most lucrative market across South Asia, accounting for nearly 50% of market share in 2021.
• China will hold leading position in East Asia and is expected to account for nearly 46% of market share.

“Growing prevalence of chronic diseases coupled with rising preference of non-invasive drug delivery system will improve the adoption of needle-free injectors. With rising demand for needle-free injectors, key players are introducing new product launches and are aiming for fast track approvals to capitalize on existing opportunities and sustain their position in the industry “says the FMI Analyst.

Who is Winning?

New product launches and approvals, agreements, and collaborations are some of the key growth strategy adopted by the key players. By focusing on these strategies, key players intend to expand their global presence and strengthen their existing product portfolio.

For instance,

• In November 2019, Antares Pharma collaborated with Idorsia for the development of a novel self-administered drug-device product.
• In June 2020, Vitaeris Inc., a biotech company was acquired by CSL Limited. The acquisition was carried out by CSL Limited to achieve the motive of addressing the unmet needs of patients.

The key market players covered by FMI include Pfizer, Inc., Gerresheimer AG, Ferring Pharmaceuticals, CSL Limited (Seqirus UK Limited) and others.

Browse Full Report:

https://www.futuremarketinsights.com/reports/needle-free-injectors-market

Key Segments Profiled In The Needle-Free Injectors Market Industry Survey

Needle-Free Injectors Market by Load:

• Needle-Free Injectors by Liquid Injections
• Needle-Free Injectors by Powder Injections
• Needle-Free Injectors by Projectile Injections

Needle-Free Injectors Market by Technology:

• Needle-Free Injectors by Spring-loaded jet injector
• Needle-Free Injectors by Battery-powered jet injector
• Needle-Free Injectors by Gas-powered jet injector

Needle-Free Injectors Market by Delivery Site:

• Needle-Free Injectors by Intra dermal injectors
• Needle-Free Injectors by Intramuscular injectors
• Needle-Free Injectors by Subcutaneous injectors

Needle-Free Injectors Market by Application:

• Needle-Free Injectors by Drug Delivery
• Needle-Free Injectors by Vaccines
• Needle-Free Injectors by Cosmetic
• Needle-Free Injectors by Others

Needle-Free Injectors Market by End User:

• Needle-Free Injectors by Home Care Settings
• Needle-Free Injectors by Long Term Care Centers

Needle-Free Injectors Market by Region:

• North America Needle-Free Injectors Market
• Latin America Needle-Free Injectors Market
• Europe Needle-Free Injectors Market
• East Asia Needle-Free Injectors Market
• South Asia Needle-Free Injectors Market
• Oceania Needle-Free Injectors Market
• Middle East & Africa Needle-Free Injectors Market

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-13960

Explore wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape:

Contrast Media Injectors Market Size was valued at US$ 1.4 Bn in 2021 and is expected to reach US$ 2.4 Bn by 2030

Needle-Free Vaccine Injectors Market Share is attributed due to the increase in prevalence of various number of chronic diseases, rising chances of communicable disease due to needle stick injuries, growing demand for vaccination and biosimilars and furthermore

Wearable Injectors Market Demand is expected to dominate the market due to early availability of advanced technologies and higher penetration of health care services

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

The global Human Identification Market value is expected to be US$ 1.08 Bn in 2022 end, as indicated by a new report of Future Market Insights (FMI). The market is further projected for a strong 8.8% CAGR during the forecast period, 2022 – 2029. A consistent rise in the number of natural disasters and fatal road accidents strongly necessitate the demand for more effective forensic DNA technologies for human identification. This would remain an important factor responsible for incremental growth of human identification market.

Human identification technology has provided satisfied results in most of the cases where no close relatives or criminal samples exist for comparison. Human identification is playing a key role in the study of human sample data required for various applications such as molecular forensic analysis, paternity & kinship study, sexual assault investigation, and several other cases of crime.

Key Takeaways – Human Identification Market Study

• Legal issues such as exploitation of privacy rights surrounding the collection of sample for comparison from suspects have always been a sensitive process.
  • Nonetheless, with the introduction of DNA phenotyping approach, sample collection has become easy without harming or exploiting dignity or integrity rights.
  • The main advantage of DNA phenotyping is that it is more focused on obtaining genetic profiles from crime scene samples. Moreover, externally visible characteristics (EVCs) are publicly available features and therefore would not involve privacy issues.
  • EVCs prediction can also be very useful in the identification of missing persons and disaster victim when no ante-mortem or close relative samples exist for comparison.
• Increased global attention for forensic identification technology has boosted the research studies, which can emerge as a promising factor for human identification.
  • In July 2019, a research study published in the American Academy of Forensic Sciences, which was performed by the Forensic Science Center (Unites States) and Michigan State University (Unites States) showed the development of a protein-based human identification capability from a single hair.

Over the time, human identification has proven to be the most precise and reliable yet a faster technology to identify crime suspects and unknown deceased individuals where minimal or no data is available for comparison. The progress of human identification technology will continue to positively influence the forensic sciences landscape, and human trafficking will be the next leg of growth.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5078

Exploring Disruptive Potential of Human Identification Market

A comprehensive view of the human identification market has led our analysts to conclude that, the market is expected to grow with a notable rate, with the continuous focus on product innovation and development coupled with advancing health systems and bringing technologies to support forensic DNA testing for identification and sample data collection used in the human identification procedures. Besides this, report findings indicate that North America and Europe capture a large share in the overall revenues of human identification market. This has been attributed to the presence of accredited forensic laboratories such as the University of North Texas Center for Human Identification (UNTCHI) which is recognized as a world leader in forensic identification, and the U.S. Federal Bureau of Investigation (FBI). The latter provides support services for free of charge forensic analysis to the FBI, and local and state law enforcement organizations.

Want More Insights?

The human identification market, the latest from the new publications of Future Market Insights, opines on the evolution of the human identification market from 2014 – 2018 and presents demand projections from 2022 – 2029 on basis of product type (instruments, software & data management, assay kits & cartridges, and other consumables), technology (polymerase chain reaction, short tandem repeats, microarray technology, capillary electrophoresis, next generation sequencing, nucleic acid extraction and purification, and rapid DNA analysis), applications (molecular forensic analysis, DNA database updating, paternity & kinship testing, crime and sexual assault investigation, missing person investigation, disaster victim identification, anthropology studies, cell line identification, population based studies, and genetic based studies), and end-users (forensic laboratories, law enforcement agencies, academic and research labs, pharmaceutical and biotech companies, contract research organizations, and others) in seven prominent regions.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-5078

Key Segments Of Human Identification Industry Survey

Human Identification Market by Product:

• Instruments
  • DNA Collection Systems
  • Electrophoresis Systems
  • Thermal Cyclers
  • Rapid DNA Analysis Systems
  • NGS Platforms
  • Microarray Scanners
  • Others
• Software & Data Management
  • Analytical Software
  • Data Interpretation
  • Data Storage
• Assay Kits & Cartridges
  • DNA Sample Preparation & Extraction Kits
  • DNA Amplification Kits
  • DNA Quantification Kits
  • Rapid DNA Analysis Cartridges
• Other Consumables

Human Identification Market by Technology:

• Polymerase Chain Reaction (PCR)
• Short Tandem Repeats (STR)
• Microarray Technology
• Capillary Electrophoresis
• Next Generation Sequencing (NGS)
• Nucleic Acid Extraction and Purification
• Rapid DNA Analysis

Human Identification Market by Application:

• Molecular Forensic Analysis
• DNA Database Updating
• Paternity & Kinship Testing
• Crime and Sexual Assault Investigation
• Missing Person Investigation
• Disaster Victim Identification
• Anthropology Studies
• Cell Line Identification
• Population-based Studies
• Genetic-based Studies

Human Identification Market by End User:

• Forensic Laboratories
• Law Enforcement Agencies
• Academic and Research Labs
• Pharmaceutical and Biotech Companies
• Contract Research Organizations
• Others

Human Identification Market by Region:

• North America Human Identification Market
• Latin America Human Identification Market
• Europe Human Identification Market
• East Asia Human Identification Market
• South Asia & Pacific Human Identification Market
• Middle East & Africa (MEA) Human Identification Market

Browse Full Report:

https://www.futuremarketinsights.com/reports/human-identification-market

Have a Look at More Valuable Insights of Healthcare

Animal Healthcare Market Size is valued at US$ 42.3 Billion in 2021. The market is likely to grow at a CAGR of 4.3% through 2027, reaching US$ 54.5 Billion by 2027

Pharmaceutical Filtration Market Share  is expected to enjoy a valuation of US$ 17.8 Bn by the end of 2022 and further expand at a CAGR of 8.7% to reach a valuation of ~US$ 41.0 Bn by 2032

Neuroendocrine Carcinoma Treatment Market Demand is set to record a market value of U.S$ 1.7 Bn in the year 2022 with a CAGR of 8.0% which indicates a positive market growth over the forecast period

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

A recently published research intelligence on the global antibiotic susceptibility testing market by Future Market Insights tracks the top five influencers pushing demand and revenue growth of the market at a global level.

• Infectious diseases, prevailing at a high pace
• Increasing rate and tenure of hospitalization
• Growing significance of early diagnostics
• Soaring research interests in microbial susceptibility testing
• Improving funding scenario for research, driven by governments & private bodies
• Antibiotic Susceptibility Testing Market is expected to reach a valuation of US$ 4.05 Bn by 2028, expanding at a CAGR of 5.2%

Growing use of antibiotics in treating even the most common health conditions remains a strong factor boosting demand for antibiotic susceptibility testing (AST).

Increasing government funds for microbial and antibiotic susceptibility testing research and consistently improving outcome of PPPs in terms of enhanced screening and evaluation of antibiotics are playing a pivotal role in strengthening the performance of antibiotic susceptibility testing market.

CDC’s ‘AMR Challenge’ involving bioMérieux is a recently announced as objective to accelerate research efforts in the field of microbial resistance.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-8574

Research in Screening of High Pathogen Concentration Samples to Propel Demand for AST

The process of spotting a specific set of genes responsible for antibiotic resistance is highly complicated when it comes to handling the complexities associated with samples that have high concentration of pathogens.

Some of the highly desirable antibiotic susceptibility testing systems that allow direct-from-sample pathogen identification through high pathogen concentration samples, are thus likely to gain high traction in coming years.

Growing research efforts in the recognition of the presence of a specific set of antibiotic resistant genes can direct efforts for identification and selection of narrow-spectrum antibiotics, which remains among the most prominent factors pushing installed base of such antibiotic susceptibility testing equipment.

A few recent launches in this segment include Genmark Diagnostics’ ePLEX Blood Culture ID Panel, Biomerieux’s BioFire FilmArray, and Luminex Corp.’s Verigene Bloodstream Infection Panel.

The report also sheds light on the increasing role of Ecommerce in the market by boosting the availability of antibiotic susceptibility testing systems. Offering improved access to susceptibility testing devices by industry’s leading brands, online retail operators have been attracting prominent vendors in the global antibiotic susceptibility testing market.

A number of vendors dealing in antibiotic susceptibility testing equipment are opting for devices that are available online owing to the significantly reduced costs and additional discounts on price.

Entry of Technologically Advanced AST Systems to Favor Market Growth

As indicated by research, the sales of antibiotic susceptibility testing equipment will witness healthy growth owing to increasing demand for specific susceptibility testing systems to define the scope of targeted therapy.

Targeting key pathogens is imperative to design a highly specific plan of treatment for a particular patient, and antibiotic susceptibility testing systems efficiently allow researchers to achieve it within a significantly short timeline.

With FDA approving a considerable number of antibiotic and microbial susceptibility testing equipment, especially in the recent past, FMI forecasts an impressive installed base for antibiotic susceptibility testing systems in coming years.

Advanced technology enabled antibiotic susceptibility testing equipment allows early diagnosis that in turn improves chances of developing targeted therapy earlier. One such recent advancement enjoying visibly growing traction in market includes oCelloScope.

This antibiotic susceptibility testing equipment by BioSense Solutions is an optical susceptibility screening system with the capability to deliver real-time, time-lapse imaging of multiple microbial combinations, simultaneously.

Recently, Thermo Fisher Scientific, Inc. and Becton, Dickinson and Company received FDA approvals for their new launches in antibiotic susceptibility testing space. Moreover, FDA passed an approval to a susceptibility testing device by bioMérieux that has an expanded capability to identify a particular pathogen.

Browse Full Report:

https://www.futuremarketinsights.com/reports/antibiotic-susceptibility-testing-market

Market segmentation

Antibiotic Susceptibility Testing Market by Product:

• Instruments
  • Automated Broth Microdilution Systems
  • Manual Broth Microdilution Systems
  • Semi-automated Broth Microdilution Systems
• Software & Services
  • Image & Analysis Software
  • Installation Services
• Kits & Reagents

Antibiotic Susceptibility Testing Market by Application:

• Sepsis
• Respiratory Infections
• Gastrointestinal Infections
• Meningitis & Encephalitis
• Endocarditis
• Others

Antibiotic Susceptibility Testing Market by End User:

• Diagnostic Laboratories
• Hospitals
• Research Laboratories

Antibiotic Susceptibility Testing Market by Region:

• North America Antibiotic Susceptibility Testing Market
• Latin America Antibiotic Susceptibility Testing Market
• Europe Antibiotic Susceptibility Testing Market
• East Asia Antibiotic Susceptibility Testing Market
• South Asia & Pacific Antibiotic Susceptibility Testing Market
• Middle East & Africa (MEA) Antibiotic Susceptibility Testing Market

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Global Antibiotic Susceptibility Testing Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Global Economic Outlook

4.1. Global Gross Domestic Product by Region & Country, 2013 – 2021

4.2. Healthcare Sector Outlook by Region & Country, 2013 – 2021

5. Key Inclusions

5.1. Development Roadmap for Antibiotic Susceptibility Testing Systems

5.2. Technology Assessment

Continued…!

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-8574

Have a Look at More Valuable Insights of Healthcare

Cystatin C Testing Market Size was valued at around US$ 194.3 Mn at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of US$ 400.4 Mn by 2032

Topical Antibiotic Pharmaceuticals Market Share covering sales outlook, demand forecast & up-to-date key trends

Veterinary Antibiotics Market Demand is worth US$ 10,904.3 million in 2022. The veterinary antibiotics market is expected to expand at a sluggish CAGR of 5.8%, and reach US$ 20,277.5 million by 2032

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global diabetic macular edema market size is expected to reach a valuation of US$ 3.7 Bn by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Bn by the end of 2032. Anti-VEGF products are leading the market in terms of drugs and they held a share of about 95.5%in 2021 in the global market. Below-mentioned factors are expected to play a pivotal role in furthering market growth

An Uptake of Intravitreal Implants by Patients to Drive Growth of the Market in North America

North America will remain dominant in the global diabetic macular edema market. An uptake of intravitreal implants by new as well as existing patients, who do not show any improvement post-treatment with intravitreal injections, is expected to sustain growth of the market in this region.

Although control of diabetes is a health priority in developed North American countries, such as the U.S., less attention is given to DME management, with diabetes-related caregivers tending to focus on treatment of diabetic complications. A major reason behind this is lack of effective treatment for DME in North America. In addition, an error exists between industry sponsored and independently run clinical trials. Most of the independent clinical trials for DME treatment lack long-term results pertaining to safety and efficacy of new combination therapies for DME. These factors are likely to inhibit growth of the market in North America.

Diabetic Macular Edema Market in Western Europe to Register the Highest CAGR through 2027

The diabetic macular edema market in Western Europe is expected to register a comparatively higher CAGR than other region segments through 2027. Pharmaceutical companies in this region are making substantial investments in research and development, new technologies, and infrastructure in order to capture a market share in the surging burden of eye diseases. This is expected to retain growth of the market in Western Europe.

However, patients in Western Europe resist the intake of intravitreal injections of anti-VEGF drugs, which leads to an instant increase in intraocular pressure causing severe pain in the head or eyes. This a major factor impeding growth of the diabetic macular edema market in Western Europe.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2697

Anti-VEGF will Remain Preferred Product in the Global Diabetic Macular Edema Market

Anti-VEGF will remain preferred product in the market, with sales estimated to expand at 1% CAGR through 2027. Eylea will continue to be the most lucrative anti-VEGF drug in the market. However, demand for corticosteroids will remain comparatively lower than anti-VEGF during the forecast period.

By product form, intravitreal injections will continue to be sought-after in the market, with sales poised to surpass US$ 4,000 Mn by 2027-end. Sales of intravitreal implants will register a comparatively higher CAGR than intravitreal injections through 2027.

Hospital pharmacy is estimated to remain the largest distribution channel in the market, as majority of countries across the globe dispense intravitreal injections and implants to outpatients by hospital pharmacies. Retail pharmacy, which mainly provides aliquots of off-label indications such as Avastin prescription, will register a comparatively low CAGR than hospital pharmacy in the market through 2027.

Key market players identified in FMI’s report include Novartis AG, Bayer AG, Allergan Plc., F. Hoffman-La Roche Ltd., Alimera Sciences Inc., Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Inc.)

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-2697

Key Segments Covered In Diabetic Macular Edema Market Report

By Drug:

• Anti-VEGF
  • Ranibizumab (Lucentis)
  • Aflibercept (Eylea)
• Corticosteroid Therapies
  • Dexamethasone (Ozurdex)
  • Fluocinolone Acetonide (Iluvien)
• Other Off-label Drugs

By Form:

• Intravitreal Injections
• Intravitreal Implants

By Distribution Channel:

• Hospitals
• Specialty Clinics
• Mail Order Pharmacies

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2697

Have a Look at More Valuable Insights of Healthcare

Diabetic Shoes Market Size is expected to reach a valuation of US$ 7.9 Bn in 2022 and is further projected to grow at a robust CAGR of 6.4% during the forecast period between 2022 and 2032

Diabetic Retinopathy Treatment Market Share  covering sales outlook, demand forecast & up-to-date key trends

Diabetic Nephropathy Market Demand  is expected to influence the demand for global diabetic nephropathy market during the forecast period of 2016-2026

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Related link :

https://faceblox.mn.co/posts/28726822

https://globalsocials.mn.co/posts/28726836

https://drujrake.mn.co/feedhttps://network-759413.mn.co/posts/28726864

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The market for transit tickets reached a value of US$ 10 billion in 2022 and is projected to reach US$ 40.46 billion in 2032, growing at a CAGR of 15% over the forecast period of 2022-2032. The market is expanding as a result of how simple it is to purchase or reserve tickets quickly and how cost-effective the service is.

The report features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period 2022 to 2028.

Ticketing is a pain point across the people who travel daily or frequently. The purchasing process has been stressful and issues of affordability has been prevalent for the lower-income riders. The presence of high speed systems like smart cards and use of smart phones in the transit ticketing has taken this market to new high.

Request a sample of this report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8443

The people now want to buy these prepaid or easy-to-use options because of the simple process and most importantly for saving time and energy rather than standing in queues.

The transit ticketing solutions are seeing more developments in the system category like for palm-scan fast-track lanes at airports, and such other devices are slowly being commercialized in the transit ticketing market.

Transit Ticketing Market: Market Participants

Examples of some of the market participants in the global transit ticketing market identified across the value chain include Rambus Incorporated, Infineon Technologies AG, AEP Ticketing Solutions, Accenture Plc, Gemalto NV, NXP Semiconductors, HID, CPI Card Group Inc., Cubic Corp., Xerox Corp., and others of transit ticketing market.

Feel free to ask your queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-8443

Transit Ticketing Market: Segmentation

The Transit Ticketing market can be segmented on the basis of product, system, application, and region.

On the basis of component, the transit ticketing market can be segmented into:

• Ticket Machine
• E-Ticket
• E-Kiosk
• E-Toll

On the basis of system, the transit ticketing market can be segmented into:

• Smart Card
• Smart Phone

 On the basis of application, the transit ticketing market can be segmented into:

• Railways & Metros
• Buses
• Personal Vehicles
• Airlines
• Ships

Related link :

https://faceblox.mn.co/posts/28726822

https://globalsocials.mn.co/posts/28726836

https://drujrake.mn.co/feedhttps://network-759413.mn.co/posts/28726864

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The global E-scooter sharing market was valued at US$ 1.1 Bn in 2022 and is expected to reach US$ 5.7 Bn by 2032 finds Future Market Insights (FMI) in a recent market survey. E-scooter sharing market likely to surge at a vigorous 17.9% CAGR during the forecast period of 2022 – 2032. In free-floating sharing commuters can pick and drop off the E-scooters from the place sanctioned by civic authorities. Hence, they can find free-floating sharing services convenient for short transit routes.

Kick Scooter Has an Upper Hand over Smart Scooters in E-scooter Sharing 

Kick scooters are more opted for by users over smart scooters in E-scooter sharing. Kick scooters are generally easy to use as compared to smart scooters, which makes the commuters choose kick scooters over smart scooters for E-scooter sharing.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15105

US to Dominate E-scooter Sharing Market throughout the Analysis Period 

US generated the highest revenue in the E- scooter-sharing market in 2021. While two of the top E-scooter sharing providers are based in the US, it holds a market share of US$ 340.9 Mn in 2021. Due to the high usage of E-scooter sharing, the market in US is expected to account for US$ 1.9 Bn in revenue by 2032.

E-scooter sharing Market: Competition Insights 

At present, E-scooter sharing manufactures are largely aiming at raising funds and gaining more customers. The key companies operating in the E-scooter sharing market are Neutron Holdings, Inc. (Lime) Cityscoot, Cooltra Motosharing, S.L.U, Bird Global Inc., Vogo Automotive Pvt. Ltd., TIER Mobility AG, Voi Technology AB, Wind Mobility,  Beam Mobility Holdings Pte. Ltd.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15105

Some of the recent developments by key providers E-scooter sharing are as follows: 

• In May 2022, San Francisco Municipal Transformation Agency (SFMTA) tested scooter sidewalk riding detection technology involving three companies Lime, Spin and Scoot. The key objective of this testing is to maintain safe sidewalks across the city. Sidewalk riding detection technology automatically detect sidewalk riding and automatically reduce the speed to a safer level.
• In April 2022, Bird announced it will provide it E-shared scooter service in Indio California, Home of Coachella and Stagecoach festivals.
• In March 2022, Chalo, an India based mobility startup acquired Vogo Automotive Pvt.Ltd. Chalo’s plan is to boost its bus ridership by providing it users to solve the last and first mile concerns.
• In March 2022, Ford announced that it will be selling its E-scooter business Spin to Tier a German e-scooter company which helped Tier to set is operations in North America.
• In November 2021, Lime announced that it has raised a funding of US$ 523 Mn and declared that it will list as public in 2022.
• In November 2021, Tier, a berlin-based E-scooter operator acquired Nextbike a German based bike-sharing platform to become Europe’s largest and diverse micro mobility provider.
• In November 2021, Bird joined with Switchback II Corp and began trading on the New York Stock Exchange (NYSE) under the name BRDS.
• In May 2021, Bird and Zig Zag joined to build a local multi-model mobility service in Italy.
• In January 2021, Vogo Automotive Pvt. Ltd. launched ‘VOGO Keep’ platform which allows people to keep the vehicle for a minimum of 12 hours and maximum of 60 days.
• In November 2019, California based E-scooter company OjO Electric Corp announced they are planning to acquire Gotcha, a scooter bike rental service.
• In January 2019, South American E-scooter service, Yellow merged with Mexican E-scooter service Grin to form the Grow mobility. After their merger Grow mobility became the largest E-scooter sharing provider in South America.

Similarly, recent developments related to companies manufacturing E-scooter sharing have been tracked by the team at Future Market Insights, which is available in the full report.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15105

More Insights Available 

Future Market Insights, in its new offering, presents an unbiased analysis of the E-Scooter Sharing Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

Key Segments Covered in E-scooter sharing Industry Survey

E-scooter sharing market by Type:

• Free-floating
• Station bound

E-scooter sharing market by Scooter Type:

• Kick Scooter
• Smart Scooter

E-scooter sharing market by Region:

• North America E-scooter sharing market
• Latin America E-scooter sharing market
• Europe E-scooter sharing market
• Asia Pacific E-scooter sharing market
• Middle East & Africa E-scooter sharing market

Related link :

https://faceblox.mn.co/posts/28726822

https://globalsocials.mn.co/posts/28726836

https://drujrake.mn.co/feedhttps://network-759413.mn.co/posts/28726864

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs